777 related articles for article (PubMed ID: 18029372)
1. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
Porrini E; Delgado P; Alvarez A; Cobo M; Pérez L; González-Posada JM; Hortal L; Gallego R; García JJ; Checa M; Morales A; Salido E; Hernández D; Torres A
Nephrol Dial Transplant; 2008 Apr; 23(4):1436-41. PubMed ID: 18029372
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus and angiotensin receptor blockers associated with changes in serum adiponectin level in new-onset diabetes after renal transplantation: single-center cross-sectional analysis.
Nishimura K; Kishikawa H; Kato T; Kobayashi Y; Fujii N; Takahara S; Ichikawa Y
Transpl Int; 2009 Jul; 22(7):694-701. PubMed ID: 19254242
[TBL] [Abstract][Full Text] [Related]
3. Pre-transplantation glucose testing for predicting new-onset diabetes mellitus after renal transplantation.
Ramesh Prasad GV; Huang M; Bandukwala F; Nash MM; Rapi L; Montada-Atin T; Meliton G; Zaltzman JS
Clin Nephrol; 2009 Feb; 71(2):140-6. PubMed ID: 19203506
[TBL] [Abstract][Full Text] [Related]
4. Magnesemia in renal transplant recipients: relation with immunosuppression and posttransplant diabetes.
Osorio JM; Bravo J; Pérez A; Ferreyra C; Osuna A
Transplant Proc; 2010 Oct; 42(8):2910-3. PubMed ID: 20970568
[TBL] [Abstract][Full Text] [Related]
5. Predictors of new onset of diabetes after transplantation in stable renal recipients.
Shehab-Eldin W; Shoker A
Nephron Clin Pract; 2008; 110(1):c1-9. PubMed ID: 18654089
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.
Roland M; Gatault P; Doute C; Büchler M; Al-Najjar A; Barbet C; Chatelet V; Marlière JF; Nivet H; Lebranchu Y; Halimi JM
Transpl Int; 2008 Jun; 21(6):523-30. PubMed ID: 18266773
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
Batista F; Auyanet I; Torregrosa JV; Oppenheimer F
Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus after kidney transplantation: a French multicentre observational study.
Kamar N; Mariat C; Delahousse M; Dantal J; Al Najjar A; Cassuto E; Lefrançois N; Cointault O; Touchard G; Villemain F; Di Giambattista F; Benhamou PY;
Nephrol Dial Transplant; 2007 Jul; 22(7):1986-93. PubMed ID: 17400559
[TBL] [Abstract][Full Text] [Related]
9. New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: a retrospective cohort study.
Ruderman I; Masterson R; Yates C; Gorelik A; Cohney SJ; Walker RG
Nephrology (Carlton); 2012 Jan; 17(1):89-96. PubMed ID: 21854501
[TBL] [Abstract][Full Text] [Related]
10. Hypomagnesemia and the risk of new-onset diabetes after liver transplantation.
Van Laecke S; Desideri F; Geerts A; Van Vlierberghe H; Berrevoet F; Rogiers X; Troisi R; de Hemptinne B; Vanholder R; Colle I
Liver Transpl; 2010 Nov; 16(11):1278-87. PubMed ID: 21031543
[TBL] [Abstract][Full Text] [Related]
11. The natural history of renal function following orthotopic heart transplant.
Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
[TBL] [Abstract][Full Text] [Related]
12. Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature.
Ghisdal L; Bouchta NB; Broeders N; Crenier L; Hoang AD; Abramowicz D; Wissing KM
Transpl Int; 2008 Feb; 21(2):146-51. PubMed ID: 17971033
[TBL] [Abstract][Full Text] [Related]
13. Pretransplant risk factors for new-onset diabetes mellitus after transplant in pediatric liver transplant recipients.
Kuo HT; Lau C; Sampaio MS; Bunnapradist S
Liver Transpl; 2010 Nov; 16(11):1249-56. PubMed ID: 21031540
[TBL] [Abstract][Full Text] [Related]
14. Predictors of new onset diabetes after renal transplantation.
Joss N; Staatz CE; Thomson AH; Jardine AG
Clin Transplant; 2007; 21(1):136-43. PubMed ID: 17302602
[TBL] [Abstract][Full Text] [Related]
15. Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus.
Imamura R; Ichimaru N; Moriyama T; Shi Y; Namba Y; Nonomura N; Matsumiya K; Toki K; Takahara S; Okuyama A
Clin Transplant; 2005 Oct; 19(5):616-21. PubMed ID: 16146552
[TBL] [Abstract][Full Text] [Related]
16. Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation.
Nagaraja P; Ravindran V; Morris-Stiff G; Baboolal K
Transpl Int; 2013 Mar; 26(3):273-80. PubMed ID: 23230898
[TBL] [Abstract][Full Text] [Related]
17. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.
Hoitsma AJ; Hilbrands LB
Clin Transplant; 2006; 20(5):659-64. PubMed ID: 16968494
[TBL] [Abstract][Full Text] [Related]
18. New-onset diabetes after transplantation: drug-related risk factors.
Santos L; Rodrigo E; Piñera C; Quintella E; Ruiz JC; Fernández-Fresnedo G; Palomar R; Gómez-Alamillo C; de Francisco A; Arias M
Transplant Proc; 2012 Nov; 44(9):2585-7. PubMed ID: 23146462
[TBL] [Abstract][Full Text] [Related]
19. Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation.
Hamer RA; Chow CL; Ong AC; McKane WS
Transplantation; 2007 Jan; 83(1):36-40. PubMed ID: 17220788
[TBL] [Abstract][Full Text] [Related]
20. New-onset cardiovascular risk factors in lung transplant recipients.
Silverborn M; Jeppsson A; Mårtensson G; Nilsson F
J Heart Lung Transplant; 2005 Oct; 24(10):1536-43. PubMed ID: 16210127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
